{"id":"vc004-capsules","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Vomiting"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By inhibiting the SGLT2 receptor, VC004 Capsules reduces glucose reabsorption in the kidneys, thereby lowering blood glucose levels. This makes it a potential treatment for type 2 diabetes.","oneSentence":"VC004 Capsules is a small molecule drug that targets the SGLT2 receptor.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:40:21.239Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes"}]},"trialDetails":[{"nctId":"NCT06658353","phase":"PHASE3","title":"Phase III Clinical Study of VC004 in Patients With Localized Advanced/ Metastatic Solid Tumors","status":"RECRUITING","sponsor":"Jiangsu vcare pharmaceutical technology co., LTD","startDate":"2025-03-17","conditions":"Locally Advanced Solid Tumor","enrollment":54},{"nctId":"NCT06619951","phase":"PHASE1","title":"A Clinical Trial to Evaluate the Effects of Itraconazole or Rifampicin on the Pharmacokinetics of VC004 Capsules in Healthy Adult Subjects","status":"COMPLETED","sponsor":"Jiangsu vcare pharmaceutical technology co., LTD","startDate":"2024-09-18","conditions":"Locally Advanced or Metastatic Solid Tumor","enrollment":56},{"nctId":"NCT06529445","phase":"PHASE1","title":"Food Effect and Relative Bioavailability Study of VC004 Capsules in Healthy Adult Subjects","status":"COMPLETED","sponsor":"Jiangsu vcare pharmaceutical technology co., LTD","startDate":"2024-07-22","conditions":"Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion","enrollment":84},{"nctId":"NCT04614740","phase":"PHASE1, PHASE2","title":"The Phase I/Phase II Clinical Study of VC004 in Patients With Localized Advanced/Metastatic Solid Tumors","status":"UNKNOWN","sponsor":"Jiangsu vcare pharmaceutical technology co., LTD","startDate":"2020-11-20","conditions":"Locally Advanced Solid Tumor, Metastatic Solid Tumor","enrollment":115},{"nctId":"NCT05528120","phase":"PHASE1","title":"Food Effect Study on the Pharmacokinetics of VC004 Capsules in Healthy Adult Subjects","status":"COMPLETED","sponsor":"Jiangsu vcare pharmaceutical technology co., LTD","startDate":"2022-10-20","conditions":"Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion","enrollment":16}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"VC004 Capsules","genericName":"VC004 Capsules","companyName":"Jiangsu vcare pharmaceutical technology co., LTD","companyId":"jiangsu-vcare-pharmaceutical-technology-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"VC004 Capsules is a small molecule drug that targets the SGLT2 receptor. Used for Type 2 diabetes.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}